FDA Brief

Company record

Leading Pharma, LLC

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Leading Pharma, LLC.

Recalls

ReportedClassFirmProduct and reason
Apr 29 Class II Leading Pharma, LLC
Drug
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.